Steven R. Hagen, SVP Pharmaceutical Development & Mfg at ALBANY MOLECULAR RESEARCH INC (AMRI), sold 6,623 shares at $16.46 ($110K) on 2015-02-18, disclosed to the SEC on 2015-02-20.
Seasonal sale ($110k) by SVP Pharmaceutical Development & Mfg — this insider has traded AMRI in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.46 | 1,250 | $21K | 18.8% |
| 2 | $16.48 | 1,623 | $27K | 24.4% |
| 3 | $16.60 | 3,750 | $62K | 56.8% |
| Total | $16.54 avg | 6,623 | $110K | 100% |
| Filing → |
| AMRI | SELL | 2016-08-10 | $21K | — | Filing → |
| AMRI | SELL | 2016-05-16 | $30K | — | Filing → |
| AMRI | SELL | 2015-08-17 | $20K | — | Filing → |